Menu Back toEfforts to Facilitate the Development of Anti-SARS-CoV-2 Monoclonal Antibodies

NiFDS-DIA Workshop 2021: Facilitating the Development and Regulations of Covid-19 Vaccines and Treatments / Current Trends in New Drug Development and Regulations

The timing is as per Korean Time Zone


Efforts to Facilitate the Development of Anti-SARS-CoV-2 Monoclonal Antibodies

Speaker(s)

John  Farley, MD, MPH

John Farley, MD, MPH

  • Director, Office of Infectious Diseases, OND, CDER
  • FDA, United States

Contact us

Please contact DIA Japan for further information.

Send Email
+81.3.6214.0574